[CYCC] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
12-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 2.73%
YoY- -121.05%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,559 -5,246 -6,491 -5,985 -6,091 -4,165 -3,182 45.20%
Tax -984 -1,138 -1,197 -998 -964 -687 -378 89.56%
NP -4,575 -4,108 -5,294 -4,987 -5,127 -3,478 -2,804 38.71%
Tax Rate - - - - - - - -
Total Cost 4,575 4,108 5,294 4,987 5,127 3,478 2,804 38.71%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -47,711,417,389,824.74 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.45 -0.41 -0.54 -0.53 -0.56 -0.50 -0.57 -14.61%
EPS Diluted -0.45 -0.41 -0.54 -0.53 -0.56 -0.50 -0.57 -14.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.